Literature DB >> 24759132

The procoagulant envelope virus surface: contribution to enhanced infection.

Edward L G Pryzdial1, Michael R Sutherland2, Wolfram Ruf3.   

Abstract

Many virus types are covered by a lipid bilayer. This structure called an envelope, is derived from the host cell and includes host- and virus-encoded proteins. Because envelope components first interact with the host, it is the trigger for infection, immunity and pathology. The roles of especially host-derived constituents are poorly understood. Focusing on herpes simplex type 1 (HSV1) as a model, we have shown that the envelope acquires the physiological initiators of coagulation from the host cell; tissue factor (TF) and procoagulant phospholipid (proPL). Unlike resting cells, where TF and proPL accessibility is carefully restricted, their expression is constitutive on the purified virus enabling factor VIIa (FVIIa)-dependant factor Xa (FXa) and thrombin generation. Interestingly, HSV1-encoded glycoprotein C (gC) on the virus enhances FXa production. In addition to coagulation proteases, HSV1 also facilitates fibrinolytic plasmin generation. HSV1 TF and gC combine to optimally enhance cultured cell infection when both FVIIa and FXa are available through protease activated receptor (PAR) 2. Plasmin also increases infection through PAR2, whereas thrombin provides an additive effect via PAR1. Thus, depending on the host cell, TF and proPL may be a general feature of enveloped viruses, enabling coagulation protease activation and PAR-mediated effects on infection.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Coagulation; Envelope; Herpes simplex virus; Protease activated receptor; Tissue factor

Mesh:

Substances:

Year:  2014        PMID: 24759132      PMCID: PMC4440795          DOI: 10.1016/j.thromres.2014.03.010

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  29 in total

1.  Activation of coagulation factor XI, without detectable contact activation in dengue haemorrhagic fever.

Authors:  E C van Gorp; M C Minnema; C Suharti; A T Mairuhu; D P Brandjes; H ten Cate; C E Hack; J C Meijers
Journal:  Br J Haematol       Date:  2001-04       Impact factor: 6.998

2.  Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening.

Authors:  Nobukazu Ishizaka; Yuko Ishizaka; Eiko Takahashi; Ei ichi Tooda; Hideki Hashimoto; Ryozo Nagai; Minoru Yamakado
Journal:  Lancet       Date:  2002-01-12       Impact factor: 79.321

3.  Viral activation of the coagulation cascade: molecular interactions at the surface of infected endothelial cells.

Authors:  O R Etingin; R L Silverstein; H M Friedman; D P Hajjar
Journal:  Cell       Date:  1990-05-18       Impact factor: 41.582

4.  A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study.

Authors:  P D Sorlie; F J Nieto; E Adam; A R Folsom; E Shahar; M Massing
Journal:  Arch Intern Med       Date:  2000-07-10

5.  Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults : the Cardiovascular Health Study.

Authors:  D S Siscovick; S M Schwartz; L Corey; J T Grayston; R Ashley; S P Wang; B M Psaty; R P Tracy; L H Kuller; R A Kronmal
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

6.  Herpes simplex virus type I does not require productive infection to induce tissue factor in human umbilical vein endothelial cells.

Authors:  N S Key; R R Bach; G M Vercellotti; C F Moldow
Journal:  Lab Invest       Date:  1993-06       Impact factor: 5.662

7.  Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event.

Authors:  Thomas W Geisbert; Howard A Young; Peter B Jahrling; Kelly J Davis; Elliott Kagan; Lisa E Hensley
Journal:  J Infect Dis       Date:  2003-11-14       Impact factor: 5.226

8.  Prothrombinase assembly on an enveloped virus: evidence that the cytomegalovirus surface contains procoagulant phospholipid.

Authors:  E L Pryzdial; J F Wright
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

9.  In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC.

Authors:  J Lubinski; L Wang; D Mastellos; A Sahu; J D Lambris; H M Friedman
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

10.  Modulation of protease activated receptor 1 influences human metapneumovirus disease severity in a mouse model.

Authors:  Laetitia Aerts; Marie-Ève Hamelin; Chantal Rhéaume; Sophie Lavigne; Christian Couture; Woojin Kim; Delia Susan-Resiga; Annik Prat; Nabil G Seidah; Nathalie Vergnolle; Beatrice Riteau; Guy Boivin
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

View more
  11 in total

Review 1.  Evasion and interactions of the humoral innate immune response in pathogen invasion, autoimmune disease, and cancer.

Authors:  Trisha A Rettig; Julie N Harbin; Adelaide Harrington; Leonie Dohmen; Sherry D Fleming
Journal:  Clin Immunol       Date:  2015-07-02       Impact factor: 3.969

2.  Cerebral venous thrombosis: a rare complication of herpes simplex encephalitis.

Authors:  M Vedani; O Toubas; M Hentzien; A Brunet; L Andreoletti; F Bani-Sadr
Journal:  J Neurovirol       Date:  2019-07-05       Impact factor: 2.643

3.  Effect of Puumala hantavirus infection on human umbilical vein endothelial cell hemostatic function: platelet interactions, increased tissue factor expression and fibrinolysis regulator release.

Authors:  Marco Goeijenbier; Joost C M Meijers; Fatih Anfasa; Jeroen M Roose; Cornelia A M van de Weg; Kamran Bakhtiari; Heikki Henttonen; Antti Vaheri; Albert D M E Osterhaus; Eric C M van Gorp; Byron E E Martina
Journal:  Front Microbiol       Date:  2015-03-24       Impact factor: 5.640

Review 4.  Antiviral anticoagulation.

Authors:  Edward L G Pryzdial; Michael R Sutherland; Bryan H Lin; Marc Horwitz
Journal:  Res Pract Thromb Haemost       Date:  2020-07-06

Review 5.  COVID-19 associated coagulopathy: Mechanisms and host-directed treatment.

Authors:  Jiří Plášek; J Gumulec; J Máca; J Škarda; V Procházka; T Grézl; Jan Václavík
Journal:  Am J Med Sci       Date:  2021-11-06       Impact factor: 3.462

Review 6.  Clinical use of thrombin generation assays.

Authors:  Nikolaus B Binder; François Depasse; Julia Mueller; Thomas Wissel; Stephan Schwers; Matthias Germer; Björn Hermes; Peter L Turecek
Journal:  J Thromb Haemost       Date:  2021-10-08       Impact factor: 16.036

7.  Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019.

Authors:  Saravanan Subramaniam; Wolfram Ruf; Markus Bosmann
Journal:  Br J Pharmacol       Date:  2021-07-07       Impact factor: 8.739

8.  Subcutaneous Administration of Low-Molecular-Weight Heparin to Horses Inhibits Ex Vivo Equine Herpesvirus Type 1-Induced Platelet Activation.

Authors:  Tracy Stokol; Priscila B S Serpa; Marjory B Brooks; Thomas Divers; Sally Ness
Journal:  Front Vet Sci       Date:  2018-05-28

9.  In silico thrombin generation: Plasma composition imbalance and mortality in human immunodeficiency virus.

Authors:  Kathleen E Brummel-Ziedins; Matthew Gissel; Jacqueline Neuhaus; Álvaro H Borges; David R Chadwick; Sean Emery; James D Neaton; Russell P Tracy; Jason V Baker
Journal:  Res Pract Thromb Haemost       Date:  2018-09-11

Review 10.  Is the COVID-19 thrombotic catastrophe complement-connected?

Authors:  Edward M Conway; Edward L G Pryzdial
Journal:  J Thromb Haemost       Date:  2020-09-18       Impact factor: 16.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.